KLK3 and neoplasm: However, most cases eventually evolve to a stage of tumor progression under ADT, characterized by an increase in serum values of prostate-specific antigen (PSA), the occurrence of new metastases—most commonly to bone or lymph nodes—or the worsening of clinical symptoms despite maintaining serum testosterone under the castration threshold (<50 ng/dL) [20].